EX-99.1 2 drr0526_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507  

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

October 26, 2023

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Ltd. (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 

This is to inform that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company at its meeting held on October 26, 2023, has approved the grant of stock options to the eligible employees under the Employees Stock Option Schemes of the Company:

 

Sl. No. Type of Option(s) Number of options granted  Value Exercise Price per share ESOP Scheme
1

Indian Stock Options

 

 

 *1,820 Fair Market Value  Rs. 5,514/- Dr. Reddy’s Stock Option Scheme, 2018
2

American Depository

Receipts (ADRs) Stock

Options

     #5,526 Fair Market Value Rs. 5,514/-

Dr. Reddy's Employees

ADR Stock Option

Scheme, 2007

 

*These options shall uniformly vest over 4 years

#These options shall uniformly vest over 3 years

 

This is for your information and records.

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

 

 

K. Randhir Singh

Company Secretary, Compliance Officer & Head-CSR